Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Orphenadrine
Drug ID BADD_D01625
Description A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
Indications and Usage Indicated for the treatment of Parkinson's disease.
Marketing Status Prescription; Discontinued
ATC Code N04AB02
DrugBank ID DB01173
KEGG ID D02599
MeSH ID D009966
PubChem ID 4601
TTD Drug ID D0D9FV
NDC Product Code Not Available
Synonyms Orphenadrine | Methyldiphenylhydramine | Lysantin | Mefenamine | Mephenamine | Norflex | Orphenadrine Citrate | Citrate, Orphenadrine | Orphenadrine Hydrochloride | Hydrochloride, Orphenadrine | Sodium Mefenamine | Mefenamine, Sodium | Disipal | Norflex Orphenadrine Citrate | Citrate, Norflex Orphenadrine | Orphenadrine Citrate, Norflex
Chemical Information
Molecular Formula C18H23NO
CAS Registry Number 83-98-7
SMILES CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Agitation19.06.02.001; 17.02.05.012--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Aplastic anaemia01.03.03.002--Not Available
Asthenia08.01.01.001--Not Available
Confusional state17.02.03.005; 19.13.01.001--
Constipation07.02.02.001--
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Feeling abnormal08.01.09.014--Not Available
Hallucination19.10.02.002--
Headache17.14.01.001--
Hypersensitivity10.01.03.003--
Mydriasis17.02.11.003; 06.05.03.004--Not Available
Nausea07.01.07.001--
Palpitations02.01.02.003--
Pruritus23.03.12.001--
Skin disorder23.03.03.007--Not Available
Somnolence17.02.04.006; 19.02.05.003--
Tachycardia02.03.02.007--Not Available
Tension19.06.02.005--Not Available
Tremor17.01.06.002--
Urinary hesitation20.02.02.009--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Vision blurred17.17.01.010; 06.02.06.007--
Vomiting07.01.07.003--
Dermatosis23.03.03.017--Not Available
Epigastric discomfort07.01.02.004--Not Available
The 1th Page    1    Total 1 Pages